Breaking news

Cyprus’ Pharmaceutical Dependence: Analyzing The EU’s Trade Dominance

by News Editor

April 15, 2025

Cyprus heavily depends on imported medicine, with only 40% of authorized pharmaceutical products available locally, as outlined in a European Commission report. Notably, around 20% of these medicines come through Article 5 of Directive 2001/83/EC, addressing unique medical needs without standard marketing approvals.

Moves Toward Better Access

Efforts are underway to improve the situation in Cyprus, as well as in Malta and Ireland. Suggested strategies include simplifying drug authorization, encouraging multi-country packaging solutions, and utilizing digital platforms to overcome language barriers.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

EU’s Pharma Trade Boom

Despite these challenges in smaller member states, the European Union recorded a remarkable pharmaceutical trade surplus last year—analyzing the trends shows a 13.5% increase in exports, reaching €313.4 billion while maintaining a €193.6 billion trade surplus.

Leading the export charge, Germany achieved €67.9 billion, with Ireland and Belgium following closely. Meanwhile, Germany also led imports, indicating dynamic intra-EU trade flows.

Global Trade Dynamics

The United States dominates as the EU’s top pharmaceutical trading partner, followed by Switzerland and the United Kingdom. These relationships underscore the EU’s strong global position in the pharmaceutical sector.

The Future Forbes Realty Global Properties

Elevating Infant Nutrition: Nara Organics Unveils Premium Organic Formula

by THEFUTURE.TEAM

July 30, 2025

The Origins Of A Vision

When Esther Hallam welcomed her daughter Nara into the world, she immediately confronted a formidable challenge: identifying a trustworthy, high-quality organic infant formula. In a U.S. market dominated by cost-cutting practices—such as the use of skim milk supplemented with oils to meet nutritional standards—Hallam observed a disconnect between established availability and uncompromised quality. Research linking corn syrup to obesity and palm oil to reduced calcium absorption only reinforced her resolve to seek a safer alternative.

Redefining Industry Standards

Frustrated by the limitations of existing options, Hallam devoted seven years to developing an organic, whole-milk formula with the expertise of leading scientists and pediatric nutritionists. Nara Organics distinguishes itself by offering the highest percentage of milk fat of any formula on the U.S. market and a significantly reduced reliance on plant-based oils. The carefully selected blend of organic sunflower, coconut, and rapeseed oils not only meets nutritional needs but also minimizes potential health risks inherent to additives like palm oil, soy, and corn syrup.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Manufacturing Excellence In Germany

Rather than manufacturing domestically—a decision influenced by previous concerns over Cronobacter contamination in American facilities—Nara Organics leverages the advanced, oxygen-controlled production environment of a German facility, widely regarded as the birthplace of powdered infant formula. Chief Marketing Officer Meika Hollender detailed that their unique manufacturing process, which minimizes oxygen exposure during can sealing, substantially extends shelf life and preserves formula integrity, setting a new standard in infant nutrition.

Strategic Investment And Market Impact

Backed by $32 million from prominent investors including AlleyCorp, BBG Ventures, Corazon Ventures, Gingerbread Capital, and Torch Capital, Nara Organics has also garnered support from high-profile celebrity investors such as Serena Williams, Gina Rodriguez, and Nicky Hilton. This robust investment positions the company at the vanguard of an organic infant formula market projected to grow from $20.7 billion in 2023 to $37 billion by 2032.

Enhancing Consumer Accessibility And Community Commitment

Nara Organics is available for purchase directly via its website, subscription models, and a dedicated mobile app that assists parents in tracking essential aspects of infant care. To underscore its commitment to community well-being, the company is donating over 1,400 cans of formula to the Good+ Foundation, which strives to alleviate multi-generational poverty by providing essential services to under-resourced families.

By merging state-of-the-art production with a commitment to organic, high-quality ingredients, Nara Organics is poised to redefine the benchmarks of infant nutrition in a competitive, evolving market.